You are here

Vaccines Areas Of Interest

Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. A formal notification regarding the status of your application will be sent once a decision is reached. Pfizer support will only be extended upon the execution of a research agreement. For any questions, please send an email to [email protected].

Question Pairs: 



Research areas to be considered for Pfizer support include:

  1. Evolving epidemiology
    1. Clinical disease burden in different:
      1. age cohorts (e.g., adolescents, infants)
      2. settings (e.g., universities, military, mass gathering, travelers)
      3. clinical condition or patient population (e.g., individuals at increased risk of meningococcal disease)
    2. Nasopharyngeal carriage in different age cohorts and settings (examples above)
    3. Disease isolates characterization – genetic characterization, diversity and evolution, region
    4. Understand incidence trend retrospectively and prospectively
  2. Disease impact – individual and community
    1. Short and long-term clinical consequences, complications 
    2. Direct and indirect costs and quality of life, social and psychological parameters
  3. Vaccine impact - in particular age cohort, setting or patient population
    1. Vaccine effectiveness 
    2. Vaccine impact on carriage dynamics – levels, density, transmission 
    3. Vaccination program impact on disease evolution and health economics
    4. Societal value of implementing meningococcal vaccination program
  4. Implementation
    1. Knowledge/awareness, attitudes/perceptions & behaviors/practices
    2. Vaccination preferences 
    3. Barriers and potential solutions 

Pneumococcal disease


Research areas to be considered for Pfizer support include:

Coming Soon!


Tick-borne Encephalitis


Research areas to be considered for Pfizer support include:

Identification of new TBE-endemic areas, virus-epidemiology

  • Tick surveillance, reservoir animals, human infection, human disease
  • Molecular characterization of TBEV and “virulence genes”
  • Characterization of circulating subtypes by region

Explore Burden of Disease:

  • Characterization of the clinical course or the natural course after infection
  • Diagnostics (e.g. adherence to guidelines, improvement of diagnostics, etc.)
  • Disease and sequelae in children and adults


  • Vaccine impact, effectiveness vaccine failures, Booster schedule (s)
  • Broad and cross neutralizing capacity
  • Closing vaccination gaps

New vaccination targets:

  • TBE in travelers (original clinical studies)
  • TBE in other exposed subjects (i.e., children, elderly)
  • Organisation of vaccination of travellers